- 1、本文档共14页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Texosome-based+drug+delivery+system+for+cancer+therapy:from+past+to+present.pdf
Cancer Biol Med 2015;12:150-162. doi: 10.7497/j.issn.2095-3941.2015.0045
REVIEW
Texosome-based drug delivery system for cancer therapy: from
past to present
1 1 2 1
Hamideh Mahmoodzadeh Hosseini , Raheleh Halabian , Mohsen Amin , Abbas Ali Imani Fooladi
1Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran; 2 Department of
Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417653861, Iran
ABSTRACT Rising worldwide cancer incidence and resistance to current anti-cancer drugs necessitate the need for new pharmaceutical
compounds and drug delivery system. Malfunction of the immune system, particularly in the tumor microenvironment,
causes tumor growth and enhances tumor progression. Thus, cancer immunotherapy can be an appropriate approach
to provoke the systemic immune system to combat tumor expansion. Texosomes, which are endogenous nanovesicles
released by all tumor cells, contribute to cell-cell communication and modify the phenotypic features of recipient cells due
to the texosomes’ ability to transport biological components. For this reason, texosome-based delivery system can be a
valuable strategy for therapeutic purposes. To improve the pharmaceutical behavior of this system and to facilitate its use in
medical applications, biotechnology approaches and mimetic techniques have been utilized. In this review, we present the
development history of texosome-based delivery systems and discuss the advantages and disadvantages of each system.
KEYWORDS Cancer thera
文档评论(0)